XLO — Xilio Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Xilio Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	19.2	198	120	44.7	55.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20.6	203	124	48.1	60.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.7	13.9	13.1	11.2	9.06
Other Long Term Assets
Total Assets	36.3	218	139	60.9	71.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.2	12.8	21.1	16	27.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	41.6	32.6	33.5	24.1	53.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-5.29	185	106	36.8	17.6
Total Liabilities & Shareholders' Equity	36.3	218	139	60.9	71.1
Total Common Shares Outstanding